Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -279.48% is 206% below its 5-year average of -91.30%, near the low end of its 5-year range (-279.48%–-51.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 83.23% below its 12-month average of -152.53%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -279.48%.
RETURN ON INVESTED CAPITAL (ROIC)
-279.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-152.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-103.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-91.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-57.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-48.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-48.47%
CURRENT VS TTM AVG
-83.23%
CURRENT VS 3Y AVG
-169.64%
CURRENT VS 5Y AVG
-206.13%
CURRENT VS 10Y AVG
-388.38%
CURRENT VS 15Y AVG
-471.13%
CURRENT VS 20Y AVG
-476.60%
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
-870.93%
vs the sector median at left
Dyadic International, Inc.
Market Cap
$16.54M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-152.53%
3Y Avg
-103.65%
5Y Avg
-91.30%
Market Cap
$16.58M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.22M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$15.91M
Return on Invested Capital (ROIC)
-41.81%
TTM Avg
-159.62%
3Y Avg
-298.97%
5Y Avg
-203.41%
Market Cap
$15.30M
Return on Invested Capital (ROIC)
-497.29%
TTM Avg
-141.17%
3Y Avg
-111.65%
5Y Avg
-80.50%
Market Cap
$15.20M
Return on Invested Capital (ROIC)
-48.04%
TTM Avg
-66.55%
3Y Avg
-57.55%
5Y Avg
-44.03%
Market Cap
$15.20M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-183.21%
3Y Avg
-122.71%
5Y Avg
-100.21%
Market Cap
$18.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$14.28M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.54M | -279.48% | -152.53% | -103.65% | -91.30% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -85.72% | -120.02% | -101.35% | -83.66% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -273.70% | -707.06% | -535.27% | -358.40% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -41.81% | -159.62% | -298.97% | -203.41% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -497.29% | -141.17% | -111.65% | -80.50% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | -48.04% | -66.55% | -57.55% | -44.03% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.20M | N/A | -183.21% | -122.71% | -100.21% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -171.06% | -106.73% | -106.73% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -67.62% | -48.11% | -41.05% | -37.60% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -46.69% | -40.71% | -34.73% | -24.39% |
ROIC
-279.5%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -279.48% |
| 2026-03-31 | -152.65% |
| 2025-12-31 | -114.75% |
| 2025-09-30 | -93.71% |
| 2025-06-30 | -122.06% |
| 2025-03-31 | -97.39% |
| 2024-12-31 | -78.86% |
| 2024-09-30 | -74.46% |
| 2024-06-30 | -92.80% |
| 2024-03-31 | -79.70% |
| 2023-12-31 | -137.91% |
| 2023-09-30 | -106.44% |
| 2023-06-30 | -93.06% |
| 2023-03-31 | -86.61% |
| 2022-12-31 | -90.25% |
| 2022-09-30 | -94.62% |
| 2022-06-30 | -98.38% |
| 2022-03-31 | -84.72% |
| 2021-12-31 | -78.57% |
| 2021-09-30 | -58.36% |
| 2021-06-30 | -51.96% |
| 2021-03-31 | -42.68% |
| 2020-12-31 | -35.24% |
| 2020-09-30 | -32.32% |
| 2020-06-30 | -28.23% |
| 2020-03-31 | -26.93% |
| 2019-12-31 | -25.88% |
| 2019-09-30 | -24.46% |
| 2019-06-30 | -23.17% |
| 2019-03-31 | -19.23% |
| 2018-12-31 | -17.89% |
| 2018-09-30 | -17.14% |
| 2018-06-30 | -15.99% |
| 2018-03-31 | -14.77% |
| 2017-12-31 | -14.26% |
| 2017-09-30 | -14.96% |
| 2017-06-30 | -13.49% |
| 2017-03-31 | -13.31% |
| 2016-12-31 | -10.32% |
| 2016-09-30 | -7.00% |
| 2016-06-30 | -4.51% |
| 2016-03-31 | -5.67% |
| 2015-12-31 | -5.07% |
| 2015-09-30 | -43.88% |
| 2015-06-30 | -61.93% |
| 2015-03-31 | -60.57% |
| 2014-12-31 | -88.36% |
| 2014-09-30 | -63.24% |
| 2014-06-30 | -57.44% |
| 2014-03-31 | 4.53% |
| 2013-12-31 | 5.15% |
| 2013-09-30 | -3.04% |
| 2013-06-30 | 0.77% |
| 2013-03-31 | 8.62% |
| 2012-12-31 | 16.67% |
| 2006-12-31 | -26.24% |
| 2006-09-30 | -48.78% |
| 2006-06-30 | -45.28% |
| 2006-03-31 | -53.57% |
| 2005-12-31 | -51.52% |
| 2005-09-30 | -59.40% |
| 2005-06-30 | -43.58% |
| 2005-03-31 | -32.51% |
| 2004-12-31 | -19.04% |
